Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Equity Ratio (2020 - 2025)

Bio Essence has reported Equity Ratio over the past 6 years, most recently at 4.91 for Q4 2025.

  • Quarterly results put Equity Ratio at 4.91 for Q4 2025, up 53.56% from a year ago — trailing twelve months through Dec 2025 was 4.91 (up 53.56% YoY), and the annual figure for FY2025 was 4.91, up 53.56%.
  • Equity Ratio for Q4 2025 was 4.91 at Bio Essence, up from 16.81 in the prior quarter.
  • Over the last five years, Equity Ratio for BIOE hit a ceiling of 0.6 in Q4 2023 and a floor of 27.64 in Q2 2025.
  • Median Equity Ratio over the past 5 years was 1.57 (2022), compared with a mean of 4.54.
  • Biggest five-year swings in Equity Ratio: surged 71.24% in 2023 and later plummeted 3225.33% in 2025.
  • Bio Essence's Equity Ratio stood at 1.43 in 2021, then plummeted by 46.39% to 2.09 in 2022, then surged by 71.24% to 0.6 in 2023, then plummeted by 1655.42% to 10.57 in 2024, then surged by 53.56% to 4.91 in 2025.
  • The last three reported values for Equity Ratio were 4.91 (Q4 2025), 16.81 (Q3 2025), and 27.64 (Q2 2025) per Business Quant data.